Article
New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Arteriosclerosis, thrombosis, and vascular biology - 1 Apr 2009
Lee Choon-Soo, Kwon Yoo-Wook, Yang Han-Mo, Kim Sung-Hwan, Kim Tae-Youn, Hur Jin, Park Kyung-Woo, Cho Hyun-Jai, Kang Hyun-Jae, Park Young-Bae, Kim Hyo-Soo
Abstract excerpt
OBJECTIVE: Mechanism of neointimal hyperplasia after vascular injury includes activation of signaling pathways and matrix metalloproteinases (MMPs) that are involved in cell proliferation and migration. Rosiglitazone, a synthetic peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agoni...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
